[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@RedChip Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::25292321.png) @RedChip RedChip

RedChip appears to be hosting investor webinars with various companies, including Bullfrog AI ($BFRG), Calidi Biotherapeutics ($CLDI), Fathom Holdings ($FTHM), and Fibrobiologics ($FBLG). These webinars aim to provide insights into the companies' growth strategies, innovative approaches, and future prospects. RedChip also introduced RedChat, a new platform for small-cap research that provides instant answers and verified data.

### Engagements: XXXXXX [#](/creator/twitter::25292321/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::25292321/c:line/m:interactions.svg)

- X Week XXXXXXX -XX%
- X Month XXXXXXXXX +169%
- X Months XXXXXXXXX +1,992%
- X Year XXXXXXXXX +607%

### Mentions: XX [#](/creator/twitter::25292321/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::25292321/c:line/m:posts_active.svg)

- X Week XXX +30%
- X Month XXX -XX%
- X Months XXXXX +373%
- X Year XXXXX +583%

### Followers: XXXXX [#](/creator/twitter::25292321/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::25292321/c:line/m:followers.svg)

- X Week XXXXX +0.41%
- X Month XXXXX +1.80%
- X Months XXXXX +9.70%
- X Year XXXXX +13%

### CreatorRank: XXXXXXX [#](/creator/twitter::25292321/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::25292321/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::25292321/influence)
---

**Social category influence**
[finance](/list/finance)  XXXX% [stocks](/list/stocks)  XXXX% [cryptocurrencies](/list/cryptocurrencies)  #5062 [automotive brands](/list/automotive-brands)  XXXX% [countries](/list/countries)  XXXX% [technology brands](/list/technology-brands)  XXXX% [currencies](/list/currencies)  XXXX% [exchanges](/list/exchanges)  XXXX% [travel destinations](/list/travel-destinations)  XXXX%

**Social topic influence**
[$sxtp](/topic/$sxtp) #1, [$nva](/topic/$nva) #1, [$byd](/topic/$byd) #6, [byd](/topic/byd) #413, [momentum](/topic/momentum) #131, [$bivi](/topic/$bivi) #4, [future of](/topic/future-of) #258, [$jpotf](/topic/$jpotf) #1, [$dkng](/topic/$dkng) #475, [$wynn](/topic/$wynn) #11

**Top accounts mentioned or mentioned by**
[@novaminerals](/creator/undefined) [@aspisotopes](/creator/undefined) [@greenpowerbus](/creator/undefined) [@calidibio](/creator/undefined) [@cirmnews](/creator/undefined) [@northwesternu](/creator/undefined) [@cityofhope](/creator/undefined) [@thelancet](/creator/undefined) [@fibrobiologics](/creator/undefined) [@jcventerinst](/creator/undefined) [@lieberinstitute](/creator/undefined) [@trinitybiotech](/creator/undefined) [@canfitepharma](/creator/undefined) [@gorillatechgrp](/creator/undefined) [@terrapower](/creator/undefined) [@atossainc](/creator/undefined) [@fatpipeinc](/creator/undefined) [@niocorp](/creator/undefined) [@xtiaerospace](/creator/undefined) [@lanternpharma](/creator/undefined)

**Top assets mentioned**
[Boyd Gaming Corporation (BYD)](/topic/$byd) [DraftKings Inc. Class A Common Stock (DKNG)](/topic/$dkng) [Wynn Resorts, Limited (WYNN)](/topic/$wynn) [Infinitar (IGT)](/topic/$igt) [PENN Entertainment Inc (PENN)](/topic/$penn) [MGM Resorts International (MGM)](/topic/$mgm) [Las Vegas Sands Corp. (LVS)](/topic/$lvs) [Caesars Entertainment, Inc. (CZR)](/topic/$czr) [VICI Properties, Inc. (VICI)](/topic/$vici) [Pfizer, Inc. (PFE)](/topic/$pfe) [MP Materials Corp. (MP)](/topic/$mp) [Perpetua Resources Corp. Common Shares (PPTA)](/topic/$ppta) [Teck Resources Limited (TECK)](/topic/$teck) [Kinross Gold Corporation (KGC)](/topic/$kgc) [NovaGold Resources Inc. (NG)](/topic/$ng) [Hecla Mining Company (HL)](/topic/$hl) [Ninja Squad Token (NST)](/topic/$nst) [Gold (XAU)](/topic/$xau) [Tesla, Inc. (TSLA)](/topic/$tsla) [Novo-Nordisk (NVO)](/topic/$nvo) [Vertex Protocol (VRTX)](/topic/$vrtx) [Eli Lilly and Company (LLY)](/topic/$lly) [Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn) [Oracle Corporation (ORCL)](/topic/$orcl) [Broadcom, Inc. (AVGO)](/topic/$avgo) [Cisco Systems Inc (CSCO)](/topic/$csco) [Fortinet Inc (FTNT)](/topic/$ftnt) [Frontier Communications Parent, Inc. Common Stock (FYBR)](/topic/$fybr) [Hewlett Packard Enterprise Co (HPE)](/topic/$hpe) [Crowdstrike Holdings Inc (CRWD)](/topic/$crwd) [Datadog Inc (DDOG)](/topic/$ddog) [Levante U.D. Fan Token (LEV)](/topic/$lev) [Rivian Automotive, Inc. (RIVN)](/topic/$rivn) [Bitcoin Scrypt (BTCS)](/topic/$btcs) [Ethereum (ETH)](/topic/ethereum) [Nexus ASA (GP)](/topic/$gp) [Schrodinger, Inc. Common Stock (SDGR)](/topic/$sdgr) [Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX)](/topic/$rxrx) [NVIDIA Corp. (NVDA)](/topic/$nvda) [AbbVie Inc (ABBV)](/topic/$abbv) [Moderna Inc (MRNA)](/topic/$mrna) [Gilead Sciences, Inc. (GILD)](/topic/$gild) [NextEra Energy Inc (NEE)](/topic/$nee) [Fluence Energy, Inc. Class A Common Stock (FLNC)](/topic/$flnc) [Bloom Energy Corporation (BE)](/topic/$be)
### Top Social Posts [#](/creator/twitter::25292321/posts)
---
Top posts by engagements in the last XX hours

"🎯 Todays the day @JackpotDigital $JPOTF CEO Jake Kalpakian to host our live investor webinar at 4:15 PM EST. Seats filling fast - register now: $JPOTF $MGM $LVS $CZR $DKNG $WYNN $BYD $VICI $IGT $PENN"  
[X Link](https://x.com/RedChip/status/1978837338437382437) [@RedChip](/creator/x/RedChip) 2025-10-16T14:56Z 5889 followers, XXX engagements


"From DoW-funding enables @NovaMinerals $NVA to accelerate next phase of strategy to onshore US antimony production in Alaska. Get the whole story: $NVA $MP $PPTA $TECK $KGC $USGO $NG $THM $WRN $HL $GPH $NST $FVL $CTGO $XAU $XAUUSD"  
[X Link](https://x.com/RedChip/status/1977818031993585963) [@RedChip](/creator/x/RedChip) 2025-10-13T19:25Z 5894 followers, XXX engagements


"🎥 Greenwich LifeSciences $GLSI: CEO Snehal Patel Discusses GP2 Immunotherapy and Phase III Strategy In our most recent interview CEO Snehal Patel outlines the companys clinical and strategic roadmap for GP2 an immunotherapy designed to prevent breast cancer recurrences in HER2-positive patients following surgery. Key Takeaways for Investors: Robust Phase IIb Data: GP2 achieved over XX% reduction in recurrence rates over five years significantly outperforming existing therapies in the adjuvant setting. Strong Safety Profile: No serious adverse events reported across XXX patients in four"  
[X Link](https://x.com/RedChip/status/1978818212507631774) [@RedChip](/creator/x/RedChip) 2025-10-16T13:40Z 5893 followers, XXX engagements


"⚛ Greenwich LifeSciences $GLSI: A Quick Look at a Promising Phase III Breast Cancer Therapy @GreenwichLS is making major strides in the fight against breast cancer. Its lead immunotherapy candidate GLSI-100 is now in a global Phase III trial (FLAMINGO-01) spanning XXX sites across the U.S. and Europe targeting up to XXX HER2+ breast cancer patients. Why This Matters to Investors: Breakthrough Potential: Aims to reduce recurrence rates by over XX% outperforming current HER2 therapies. Robust Safety Profile: Supported by ongoing Data Safety Monitoring Board reviews with no changes required."  
[X Link](https://x.com/RedChip/status/1978093442627457045) [@RedChip](/creator/x/RedChip) 2025-10-14T13:40Z 5893 followers, 39.9K engagements


"📅 X Week to Go: Dont miss XX Degrees Pharmaceuticals $SXTP Live Investor Webinar on Oct. XX at 4:15 PM EST. Learn about pipeline growth market expansion and key milestones. Register Here: $SXTP $VRTX $LLY $NVO $PFE $VALN $REGN"  
[X Link](https://x.com/RedChip/status/1978431182044811621) [@RedChip](/creator/x/RedChip) 2025-10-15T12:02Z 5889 followers, XXX engagements


"🧬 $LTRN: AI Platform Transforms Drug Discovery @LanternPharmas RADR platform dramatically speeds up early-stage cancer drug research. Why This Matters to Investors: XX% shorter development timelines XX% reduction in trial costs XX higher odds of clinical success Learn more: $LTRN $SDGR $RXRX $NVDA $ABBV $GILD $MRNA"  
[X Link](https://x.com/RedChip/status/1977752474652991688) [@RedChip](/creator/x/RedChip) 2025-10-13T15:05Z 5893 followers, 57.4K engagements


"🧠 Jupiter Neurosciences: Targeting $50B+ in Neurological and Rare Disease Markets Jupiter Neurosciences $JUNS is redefining CNS treatment with JOTROL a patented resveratrol formulation offering 9x higher bioavailability than traditional options without GI side effects. Why Investors Should Watch: Multiple Phase X Trials: Launching in 2025 across Alzheimer's Parkinsons and rare diseases like MELAS and MPS-I. Massive Market Opportunity: Targeting unmet needs in markets exceeding $50B in potential. Diversified Strategy: Clinical pipeline backed by @Harvard & @Georgetown + a near-term DTC"  
[X Link](https://x.com/RedChip/status/1975198162739458254) [@RedChip](/creator/x/RedChip) 2025-10-06T13:55Z 5888 followers, XXX engagements


"🎥 XX Degrees Pharmaceuticals: Watch the 30-Second Investor Overview XX Degrees Pharmaceuticals $SXTP is advancing next-gen therapies for infectious diseases with a strong focus on late-stage clinical assets. Why Investors Should Watch: Revenue Momentum: ARAKODA malaria prevention sales surged XXX% YoY in Q3 2024. Clinical Expansion: Tafenoquine entering a pivotal trial for babesiosis a growing tick-borne threat with 47000 U.S. cases annually. Capital-Efficient Model: Leverages existing data to accelerate development and reduce risk across its pipeline. See the Big Picture in Just XX Seconds:"  
[X Link](https://x.com/RedChip/status/1975213237990809829) [@RedChip](/creator/x/RedChip) 2025-10-06T14:55Z 5889 followers, XXX engagements


"🎥 Lantern Pharma $LTRN: Precision Oncology Powered by AI In our recent interview CEO Panna Sharma detailed how @LanternPharma is leveraging its RADR AI platform to accelerate cancer drug development and cut early-stage costs by up to 80%. Key Takeaways for Investors: Global Oncology AI Platform: RADR integrates 200B+ datapoints to guide precision drug development reduce costs and improve trial success rates. Clinical Pipeline: Three assets in trials - LP-300 (Phase X $4B non-small cell lung cancer never-smoker market) LP-184 (DDR-deficient tumors $10B+ potential) LP-284 (aggressive B-cell"  
[X Link](https://x.com/RedChip/status/1978839620310769673) [@RedChip](/creator/x/RedChip) 2025-10-16T15:05Z 5893 followers, 22.9K engagements


"🚨 X Day Left: FatPipe $FATN Investor Webinar Dont miss insights from Ragula Bhaskar as he outlines growth across SD-WAN SASE and NMS: markets set to exceed $49B by 2030. 📆 Tomorrow  4:15 PM EST 🔗 Register Here: $FATN $AVGO $CSCO $ORCL $HPE $FTNT $FYBR $CRWD $DDOG"  
[X Link](https://x.com/RedChip/status/1978069298368180421) [@RedChip](/creator/x/RedChip) 2025-10-14T12:04Z 5888 followers, XXX engagements


"📺 BioVie $BIVI: CEO Cuong Do Discusses Alzheimers Trial Liver Therapy Breakthroughs and Whats Next Investors don't miss our latest interview with $BIVI CEO Cuong Do as he breaks down the company's pivotal clinical programs and upcoming milestones: Alzheimers in Focus: A potentially pivotal Phase X trial of NE3107 in mild-to-moderate Alzheimer's is underway: targeting one of the worlds most urgent unmet medical needs. Liver Disease Innovation: BIV201 aims to treat life-threatening complications of liver cirrhosis linked to hepatitis NASH and alcohol-related damage. Why It Matters: $BIVI is"  
[X Link](https://x.com/RedChip/status/1978439467200324008) [@RedChip](/creator/x/RedChip) 2025-10-15T12:35Z 5891 followers, XXX engagements


"Learn more about Bimergen's projects and sign up for $BESS news alerts: $BESS $NEE $FLNC $STEM $BE $ENPH $TSLA $GNRC $EOSE"  
[X Link](https://x.com/RedChip/status/1978171706238763319) [@RedChip](/creator/x/RedChip) 2025-10-14T18:51Z 5887 followers, XXX engagements


"🚨 Todays the Day Phoenix Motor (OTC: PEVM / PEVMD) goes live at 4:15 PM EST. Dont miss this investor webinar exploring one of the commercial EV sectors most compelling innovators. 🔗 $PEVM $BYD $LEV $TSLA $RIVN"  
[X Link](https://x.com/RedChip/status/1962854795095486588) [@RedChip](/creator/x/RedChip) 2025-09-02T12:27Z 5888 followers, XXX engagements


"Join FatPipe's CEO for our investor webinar: live now $FATN $AVGO $CSCO $ORCL $HPE $FTNT $FYBR $CRWD $DDOG"  
[X Link](https://x.com/RedChip/status/1978558504039309788) [@RedChip](/creator/x/RedChip) 2025-10-15T20:28Z 5889 followers, XXX engagements


"🏥 NDT Pharmaceuticals $NDTP Good Salt Life Deploys ByoCart Disinfection System at Baptist Hospital Good Salt Life a subsidiary of NDT Pharmaceuticals has deployed its ByoCart Disinfection System at Baptist Hospital a flagship facility of @BaptistHealthSF to strengthen patient safety and environmental health. ByoCart simultaneously disinfects surfaces and purifies air using induction-charged air-scrubbing technology setting a new standard for institutional hygiene. Baptist Hospitals order further confirms growing industry demand for improved disinfection solutions. Read the Full Announcement:"  
[X Link](https://x.com/RedChip/status/1977728102584197428) [@RedChip](/creator/x/RedChip) 2025-10-13T13:28Z 5888 followers, XXX engagements


"🚨 Tomorrow @JackpotDigital $JPOTF CEO Jake Kalpakian goes live at 4:15 PM EST. Dont miss insights into the companys expansion and growth opportunities. 🔗 Register here: $JPOTF $MGM $LVS $CZR $DKNG $WYNN $BYD $VICI $IGT $PENN"  
[X Link](https://x.com/RedChip/status/1978455594693460418) [@RedChip](/creator/x/RedChip) 2025-10-15T13:39Z 5889 followers, XXX engagements


"📊 BTCS $BTCS: An Ethereum-First Public Blockchain Company In just XX seconds see how @NasdaqBTCS is scaling Ethereum infrastructure with: Proprietary Builder+ platform driving block building revenue Validator node operations generating staking rewards A DeFi/TradFi flywheel designed to enhance shareholder value Watch our quick overview and discover why $BTCS is positioned as one of the most sophisticated public Ethereum plays. Overview Here: $BTCS $COIN $RIOT $HIVE $MARA $NVDA $ETH $SQ"  
[X Link](https://x.com/RedChip/status/1978440728331112949) [@RedChip](/creator/x/RedChip) 2025-10-15T12:40Z 5889 followers, XXX engagements


"📺 FatPipe: Watch our 30-Second Investor Overview @FatPipe_Inc $FATN a pioneer in secure networking is scaling its enterprise-grade SD-WAN and SASE solutions across North America and Southeast Asia. Key Highlights for Investors: FY24 Revenue: $17.9M Net Income: $4.4M (24.4% margin) 2500+ customers across government finance healthcare and retail Expanding footprint in Southeast Asia & Mexico Positioned in a $49B+ market growing at double-digit CAGR With patented technology a 90%+ gross margin SaaS model and proven profitability $FATN offers exposure to cutting-edge mission-critical enterprise"  
[X Link](https://x.com/RedChip/status/1978089664062836790) [@RedChip](/creator/x/RedChip) 2025-10-14T13:25Z 5893 followers, 39.9K engagements


"🚨 ASP Isotopes $ASPI Investor Webinar: Unlocking the Future of Critical Materials Join @ASPIsotopes for a live investor webinar on Tuesday October 28th at 4:15 PM ET. The event features a brief presentation from management followed by a deep-dive Q&A offering retail and institutional investors direct access to the team behind one of the most ambitious isotope and nuclear fuel platforms globally. From medical isotopes to quantum computing and HALEU supply $ASPI is rapidly scaling with multiple enrichment facilities now online. Reserve Your Spot: $ASPI $SMR $NNE $OKLO $UUUU $CEG $VST $CCJ $UEC"  
[X Link](https://x.com/RedChip/status/1978068543863218353) [@RedChip](/creator/x/RedChip) 2025-10-14T12:01Z 5888 followers, XXX engagements


"PRE-MARKET MOVER ALERT: Xortx Therapeutics $XRTX up +43% on +400x average daily volume in premarket trading following news of acquisition of renal anti-fibrotic therapeutic program. Read the full news: $XRTX $AMGN $SYBX $ANIP $FBIO $SELB $PFE"  
[X Link](https://x.com/RedChip/status/1979161356705137076) [@RedChip](/creator/x/RedChip) 2025-10-17T12:23Z 5894 followers, XXX engagements


"🧬 Aptevo Therapeutics $APVO: XXX% Remission in Cohort X Reinforces Mipletamigs Differentiated Position in AML Aptevo announced a XXX% remission rate (CR/CRi) in Cohort X of its RAINIER trial evaluating mipletamig its first-in-class CD123 x CD3 bispecific antibody in combination with venetoclax + azacitidine for newly diagnosed AML patients unfit for intensive chemotherapy. Crucially no dose-limiting toxicities or cytokine release syndrome (CRS) have been observed to date across the trial. Why It Matters: High-Impact Efficacy: XXX% remission in Cohort X with XX% of patients achieving"  
[X Link](https://x.com/RedChip/status/1978070835794497942) [@RedChip](/creator/x/RedChip) 2025-10-14T12:10Z 5893 followers, 35.2K engagements


"🚨 Americas next mineral crisis is unfolding and @NovaMinerals $NVA could be at the center of the solution. China and Russia dominate the global antimony supply: a critical element for EVs energy storage and defense. $NVA's Estelle Project in Alaska offers a rare U.S. source plus a massive multi-million-ounce gold deposit to anchor it. Critical minerals. Tier X gold. One project massive potential. Discover why $NVA could be a game-changer: $NVA $MP $PPTA $TECK $KGC $USGO $NG $THM $WRN $HL $GPH $NST $FVL $CTGO $XAU $XAUUSD"  
[X Link](https://x.com/RedChip/status/1978104761715953783) [@RedChip](/creator/x/RedChip) 2025-10-14T14:25Z 5893 followers, 30.8K engagements


"🫁 Lung Cancer Rising in Non-Smokers - Heres How @LanternPharma $LTRN Is Responding $LTRN's lead candidate LP-300 is designed specifically for this growing patient group. In its Phase X Harmonic trial LP-300 has demonstrated an XX% clinical benefit rate in never smokers with Non-Small Cell Lung Cancer (NSCLC). In one case achieving a complete durable response in the targeted cancer lesions following treatment. 💡 Why Investors Should Pay Attention: 150000 new cases annually of NSCLC in never smokers LP-300 targets key TKI mutations common in these patients (EGFR ALK MET) $4B+ global market"  
[X Link](https://x.com/RedChip/status/1978839613381751126) [@RedChip](/creator/x/RedChip) 2025-10-16T15:05Z 5894 followers, XXX engagements


"🎥 @ASPIsotopes: One-Minute Insight into a High-Impact Growth Story $ASPI is pioneering the next frontier of isotope production right as global demand surges in nuclear medicine quantum computing and clean energy. Backed by $60M+ in cash and a scalable business model $ASPI is now commercializing key isotopes like Ytterbium-176 and Carbon-14 under long-term supply agreements. Why This Matters for Investors Transition to Revenue: From R&D to commercialization in 2025 Strategic Partnerships: Backed by TerraPower and South Africas Necsa Breakthrough Technology: Proprietary Aerodynamic and Quantum"  
[X Link](https://x.com/RedChip/status/1978796831006957947) [@RedChip](/creator/x/RedChip) 2025-10-16T12:15Z 5892 followers, XXX engagements


"🚀 BioVie Inc. Targeting Major Breakthroughs in Neurology & Liver Disease $BIVI is advancing innovative therapies in high-need markets including Alzheimers Parkinsons Long COVID and liver cirrhosis. With multiple clinical-stage assets and a fully funded Parkinsons Phase 2b trial launching in late 2024 the company is gearing up for a catalyst-rich year ahead. Why This Matters for Investors: Multiple Shots on Goal: Active programs in Alzheimers (Phase 3) Parkinsons (Phase 2b) Long COVID (Phase 2) and liver disease (Phase 3-ready). Regulatory Momentum: FDA Fast Track status for BIV201 in liver"  
[X Link](https://x.com/RedChip/status/1978801878214332643) [@RedChip](/creator/x/RedChip) 2025-10-16T12:35Z 5891 followers, XXX engagements


"📢 Nova Minerals $NVA: Secures Land for U.S. Antimony Refinery at Alaskas Port MacKenzie @NovaMinerals has locked in a 42.8-acre commercial industrial site near Port MacKenzie to establish a U.S.-based antimony refinery advancing its plan to produce military-spec antimony by 2026/27. With strong state and federal support $NVA is rapidly building a vertically integrated mine-to-refinery supply chain supporting U.S. critical mineral independence. Read the Full Announcement: $NVA $MP $PPTA $TECK $KGC $USGO $NG $THM $WRN $HL $GPH $NST $FVL $CTGO $XAU $XAUUSD"  
[X Link](https://x.com/RedChip/status/1976631204469158292) [@RedChip](/creator/x/RedChip) 2025-10-10T12:49Z 5889 followers, 1422 engagements


"📢 NioCorp Developments: CEO Mark Smith on U.S. DoD/DoW Grant & Financing Momentum @NioCorp $NB Elk Creek Project is gaining critical support to become Americas first scandium mine-to-market supply chain. In our latest interview CEO Mark Smith discusses: $10M U.S. defense grant to accelerate feasibility study updates Potential $800M Export-Import Bank of the United States financing backed by U.K. and German agencies Binding offtake agreements with tier-one customers like thyssenkrupp CMC Cometals and Traxys North America Elk Creeks ability to make the U.S. a scandium superpower reducing"  
[X Link](https://x.com/RedChip/status/1975933019853607110) [@RedChip](/creator/x/RedChip) 2025-10-08T14:35Z 5886 followers, 55.6K engagements


"🎥 Investors: See Why @ASPIsotopes $ASPI Is Poised to Lead the Global Isotope Market Demand for enriched isotopes is soaring powering breakthroughs in healthcare semiconductors and next-gen nuclear energy. $ASPI is meeting this challenge with: Commercial production of high-value isotopes like Ytterbium-176 Carbon-14 and Silicon-28: each supported by multi-year supply agreements. Breakthrough Quantum Enrichment technology delivering isotopes faster cheaper and with less environmental impact. Strategic partnerships with TerraPower and Necsa targeting the multibillion-dollar HALEU nuclear fuel"  
[X Link](https://x.com/RedChip/status/1977709668039373307) [@RedChip](/creator/x/RedChip) 2025-10-13T12:15Z 5886 followers, XXX engagements


"🧠 Nexalin Technology $NXL: Strengthening Scientific Leadership in Alzheimers and TBI Programs Nexalin Technology has expanded its Scientific Advisory Board with the appointment of Dr. Robert Rothstein a renowned expert in mental healthcare and emergency medicine. Dr. Rothstein will play a key role in advancing Nexalins upcoming FDA submissions for its Deep Intracranial Frequency Stimulation (DIFS) technology targeting Alzheimers disease and Traumatic Brain Injury (TBI). Dr. Rothsteins 40+ years in clinical medicine and research at institutions like @JohnsHopkins and @UCLA bolster Nexalins"  
[X Link](https://x.com/RedChip/status/1977728763447111763) [@RedChip](/creator/x/RedChip) 2025-10-13T13:30Z 5888 followers, XXX engagements


"📈 Enlivex Therapeutics $ENLV: CEO Oren Hershkovitz Discusses Strategic Path Forward in Macrophage Reprogramming In this in-depth interview CEO Oren Hershkovitz outlines how Enlivex is advancing Allocetra an off-the-shelf cell therapy aimed at restoring macrophage homeostasis across inflammatory and autoimmune conditions. Key Highlights: Clinical Validation: Statistically significant 6-month data in knee osteoarthritis sustained pain reduction and functional gains support continued development. Pipeline Expansion: Targeting basal thumb and TMJ OA plus psoriatic arthritis: each addressing high"  
[X Link](https://x.com/RedChip/status/1978088428118942209) [@RedChip](/creator/x/RedChip) 2025-10-14T13:20Z 5886 followers, XXX engagements


"🚨 In times of uncertainty gold has always been the ultimate safe haven asset; @NovaMinerals is sitting on a massive XXX million ounce gold resource in one at its Estelle Project in Alaskas legendary Tintina Gold Belt. $NVA's district-scale opportunity currently valued at a fraction of its peers also includes a rich antimony resource that offers additional upside as mineral supply chains tighten globally. See why $NVA could be the next big gold story: $NVA $TECK $KGC $USGO $NG $THM $WRN $HL $GPH $NST $FVL $CTGO $XAU $XAUUSD"  
[X Link](https://x.com/RedChip/status/1978829539368141208) [@RedChip](/creator/x/RedChip) 2025-10-16T14:25Z 5889 followers, XXX engagements


"PRE-MARKET MOVER ALERT: New Era Energy & Digital $NUAI up +21% $NUAI $XOM $SHEL $CVX $COP $SLB $BKR $HAL $HON"  
[X Link](https://x.com/RedChip/status/1978441601769771373) [@RedChip](/creator/x/RedChip) 2025-10-15T12:43Z 5888 followers, XXX engagements


"🚨 BioVie $BIVI: Advancing the First New Parkinsons Treatment in XX Years With over 1M Americans living with Parkinsons @BioVie_Pharma is developing bezisterim: a first-in-class oral therapy targeting inflammation and insulin resistance. Following promising Phase X results $BIVI has launched its Phase 2b Parkinsons trial and recently enrolled the first patient. Watch our 30-sec overview: $BIVI $PACB $VYGR $PFE $MRK"  
[X Link](https://x.com/RedChip/status/1978077080052027651) [@RedChip](/creator/x/RedChip) 2025-10-14T12:35Z 5886 followers, XXX engagements


"🎙 Investor Spotlight: Geoff Dow CEO of XX Degrees Pharmaceuticals $SXTP Shares Strategic Vision $SXTP is taking aim at infectious diseases with precision. In our latest interview President & CEO Geoff Dow discusses how $SXTP is advancing its antifungal and antiviral pipeline while scaling commercialization of ARAKODA: an FDA-approved malaria prophylactic with XXX% YoY sales growth in Q3 2024. Why Investors Should Tune In: Strong Market Traction: ARAKODA is revenue-generating and FDA-approved with growth accelerating. Strategic Expansion: Upcoming pivotal study in babesiosis a tick-borne"  
[X Link](https://x.com/RedChip/status/1975938021972124158) [@RedChip](/creator/x/RedChip) 2025-10-08T14:55Z 5889 followers, 67K engagements


"📢 Unlock the Future of Cancer Treatment in Just XX Seconds @CalidiBio $CLDI invites investors to watch its brief company overview video spotlighting its next-gen immuno-oncology platforms designed to target high-impact cancer markets worth up to $XX billion annually. Why It Matters for Investors: Multiple Clinical Programs: Advancing treatments for glioblastoma triple-negative breast cancer lung cancer and more. Breakthrough Delivery Platforms: Protect and enhance the power of oncolytic viruses improving patient outcomes. Strong Pipeline & Analyst Confidence: Three buy ratings with an"  
[X Link](https://x.com/RedChip/status/1977719746641502685) [@RedChip](/creator/x/RedChip) 2025-10-13T12:55Z 5893 followers, 49.7K engagements


"🚨 Starting soon @JackpotDigital $JPOTF CEO Jake Kalpakian live investor webinar at 4:15 PM EST. 👉 Last chance to join: $JPOTF $MGM $LVS $CZR $DKNG $WYNN $BYD $VICI $IGT $PENN"  
[X Link](https://x.com/RedChip/status/1978913882258247795) [@RedChip](/creator/x/RedChip) 2025-10-16T20:00Z 5889 followers, XXX engagements


"Nova Minerals $NVA closed up over XXX% on Trump critical mineral discussion news. $NVA $MP $PPTA $TECK $KGC $USGO $NG $THM $WRN $HL $GPH $NST $FVL $CTGO $XAU $XAUUSD"  
[X Link](https://x.com/RedChip/status/1978189267189768287) [@RedChip](/creator/x/RedChip) 2025-10-14T20:00Z 5888 followers, XXX engagements


"🎙 Investor Spotlight: Geoff Dow CEO of XX Degrees Pharmaceuticals $SXTP Shares Strategic Vision XX Degrees Pharmaceuticals is taking aim at infectious diseases with precision. In our latest interview President & CEO Geoff Dow discusses how $SXTP is advancing its antifungal and antiviral pipeline while scaling commercialization of ARAKODA: an FDA-approved malaria prophylactic with XXX% YoY sales growth in Q3 2024. Why Investors Should Tune In: - Strong Market Traction: ARAKODA is revenue-generating and FDA-approved with growth accelerating. - Strategic Expansion: Upcoming pivotal study in"  
[X Link](https://x.com/RedChip/status/1955644292170436904) [@RedChip](/creator/x/RedChip) 2025-08-13T14:55Z 5889 followers, XXX engagements


"🎙 Liberty Star Minerals $LBSR: Exclusive Leadership Interview - Unlocking Arizonas Next Major Gold & Copper Discoveries $LBSR sits at the forefront of U.S. mineral exploration with two high-impact projects in Arizona: Red Rock Canyon: Bonanza-grade gold assays including samples exceeding X oz/ton position this near-surface bulk-tonnage project for near-term development. Hay Mountain: First-ever drilling in 2024 confirms a large-scale copper-gold porphyry system in Arizonas world-class Laramide copper belt. Why This Matters to Investors: Dual exposure to high-grade gold and large-scale copper"  
[X Link](https://x.com/RedChip/status/1975200655720566859) [@RedChip](/creator/x/RedChip) 2025-10-06T14:05Z 5888 followers, XXX engagements


"📈 Gorilla Technology $GRRR: Analyst Target Raised to $XX Amid Transformative Growth Alliance Global Partners has nearly doubled its price target on @GorillaTechGrp lifting it to $XX per share. The upgrade follows the companys $1.44B partnership with Freyer to build AI-powered data center infrastructure in Southeast Asia. Why Investors Should Tune In: Backlog Expansion: AGP projects an incremental $100M added to $GRRR's backlog up sharply from pre-deal levels of $85M. Earnings Outlook: 2026 adjusted EBITDA forecast raised from $28M to $89M on just the first $300M phase of the Freyer contract."  
[X Link](https://x.com/RedChip/status/1978458368328045035) [@RedChip](/creator/x/RedChip) 2025-10-15T13:50Z 5893 followers, 29.4K engagements


"🎥 30-Second Investor Snapshot on Trinity Biotech $TRIB Trinity Biotech is making bold moves in diagnostics and diabetes care expanding into the high-growth wearable biosensor market. Why This Matters for Investors: Strategic Expansion: Recent acquisition of Waveforms biosensor assets positions $TRIB to tap into the booming continuous glucose monitoring (CGM) space. Global Reach: Active in 75+ countries with established diagnostic products targeting infectious diseases and diabetes management. Growth Potential: Combining clinical diagnostics with wearable tech for long-term revenue"  
[X Link](https://x.com/RedChip/status/1975576954649665863) [@RedChip](/creator/x/RedChip) 2025-10-07T15:00Z 5894 followers, XXX engagements


"💊 XX Degrees Pharmaceuticals $SXTP: Launching First-of-Its-Kind Chronic Babesiosis Study XX Degrees Pharmaceuticals is launching the B-FREE Chronic Babesiosis Study (NCT06656351) the worlds first Phase X trial evaluating a potential therapeutic for chronic babesiosis using the companys ARAKODA (tafenoquine) regimen. The 12-month study begins in early November and will assess efficacy and safety in patients suffering from this debilitating tick-borne illness. Why This Matters to Investors: First Global Study of Its Kind: Addresses a major unmet medical need with no current FDA-approved"  
[X Link](https://x.com/RedChip/status/1976274116089872498) [@RedChip](/creator/x/RedChip) 2025-10-09T13:10Z 5889 followers, XXX engagements


"🎥 @NioCorp $NB: XX Seconds Investors Should See Construction-ready U.S. critical minerals project with all major permits secured Offtake visibility: XX% of planned niobium output under long-term agreements plus the largest scandium sales deal on record Financing momentum: U.S. EXIM processing about $800M in debt with potential $400M in additional ECA support and a Department of War grant of up to $10M Scandium strengthens aluminum and niobium strengthens steel: vital for aerospace and defense applications where lighter stronger alloys drive performance. Watch our 30-second overview: $NB $MP"  
[X Link](https://x.com/RedChip/status/1977744894018928853) [@RedChip](/creator/x/RedChip) 2025-10-13T14:35Z 5894 followers, 50.3K engagements


"🎙 Must-Watch Interview: Fraser Atkinson CEO of @GreenPowerBus Talks EV Strategy & Growth $GP is driving the electrification of transportation with a purpose-built all-electric lineup of buses and trucks. With 900+ zero-emission vehicles built and $90M+ in revenue generated over the past three years the company is capitalizing on strong regulatory tailwinds and growing demand for clean transit solutions. Why Investors Should Tune In: Undervalued Opportunity: Trades at 1x TTM sales well below peers like Workhorse $WKHS. Profitability Edge: Only peer with positive gross profit. Strategic"  
[X Link](https://x.com/RedChip/status/1976645158117466135) [@RedChip](/creator/x/RedChip) 2025-10-10T13:45Z 5889 followers, XXX engagements


"🛫 @XTIAerospace $XTIA: Unveiling the Future of Regional Air Mobility CEO Scott Pomeroy outlines how the TriFan XXX is positioned to transform both commercial and government aviation with unmatched versatility: VTOL flexibility + business turboprop speed and range Nearly 1000-mile missions at 300+ mph without new infrastructure Early market validation: 140+ conditional pre-orders and XXX reservations/options representing $3B potential revenue Why It Matters for Investors: The TriFan XXX addresses a massive market gap between short-range eVTOLs and traditional fixed-wing aircraft with"  
[X Link](https://x.com/RedChip/status/1977755009400836269) [@RedChip](/creator/x/RedChip) 2025-10-13T15:15Z 5893 followers, 43.9K engagements


"💡 Join Nexalin Technology $NXL CEO Mark White for an Exclusive Investor Webinar Nexalin is redefining mental healthcare with its proprietary Deep Intracranial Frequency Stimulation (DIFS) a breakthrough non-invasive technology addressing global mental health and neurological disorders. Peer-reviewed clinical data published in Radiology show Nexalins Gen-2 SYNC 40-Hz DIFS device significantly improved cognitive performance and brain connectivity in Alzheimers patients validating its mechanism of action and safety profile. Wednesday October XX 2025 4:15 PM ET Register Here: $NXL $VRTX $STIM"  
[X Link](https://x.com/RedChip/status/1978450287879762285) [@RedChip](/creator/x/RedChip) 2025-10-15T13:18Z 5890 followers, XXX engagements


"⚡ New from the Financial Times: Battery Storage Emerges as the Backbone of the Clean Power Economy With battery installations tripling in markets like California and global capacity projected to rise tenfold by 2035 grid-scale Battery Energy Storage Systems (BESS) are transforming global power reliability. Enter Bimergen $BESS: Powering the Next Phase of Energy Storage Growth XX in-house projects totaling XXX GW across major grid markets. Long-term offtake agreements with institutional partners ensuring recurring cash flows. Monetization of up to XX% of project CapEx at launch via federal"  
[X Link](https://x.com/RedChip/status/1978171501812548074) [@RedChip](/creator/x/RedChip) 2025-10-14T18:50Z 5887 followers, XXX engagements


"🔔 Starting Soon: Phoenix Motor $PEVM Live Investor Webinar Join us now and hear how Phoenix is building the future of EVs starting with $200M+ in revenue opportunities. 🔗 $PEVM $BYD $LEV $TSLA $RIVN"  
[X Link](https://x.com/RedChip/status/1962968814208819510) [@RedChip](/creator/x/RedChip) 2025-09-02T20:00Z 5888 followers, XXX engagements


"⛏ @NovaMinerals $NVA: Strategic Investment in High-Grade Gold & Antimony Explorer Adelong Gold Nova has acquired a XXX% cornerstone stake in Adelong Gold $ADG a near-term gold and antimony producer with promising assets in Australia and Brazil: aligning with Novas strategy to unlock value in high-growth resource-rich districts. Why This Matters to Investors: Portfolio Diversification: Enhances $NVA's exposure to near-term gold production and critical minerals through a diversified asset base. High-Impact Exploration: Adelongs Lauriston project has shown standout results (8m @ XXX g/t Au) with"  
[X Link](https://x.com/RedChip/status/1965399002750353651) [@RedChip](/creator/x/RedChip) 2025-09-09T12:56Z 5889 followers, XXX engagements


"💡 The Future of Drug Development in Just XX Seconds BullFrog AI $BFRG offers a quick look at how its BullFrog Data Networks platform powered by proprietary bfLEAP technology is helping biopharma companies improve drug discovery and development outcomes. Why It Matters to Investors: AI-Driven Efficiency: $BFRG's platform uncovers hidden insights in complex datasets accelerating clinical trials and drug repurposing. Market-Ready Solutions: Designed to help resource-limited biopharma firms optimize R&D while supporting larger enterprises in reducing drug development risks. Strategic"  
[X Link](https://x.com/RedChip/status/1977712195698827386) [@RedChip](/creator/x/RedChip) 2025-10-13T12:25Z 5893 followers, 65.3K engagements


"🧬 Aptevo Therapeutics $APVO: XXX% Remission in Cohort X Reinforces Mipletamigs Differentiated Position in AML Aptevo announced a XXX% remission rate (CR/CRi) in Cohort X of its RAINIER trial evaluating mipletamig its first-in-class CD123 x CD3 bispecific antibody in combination with venetoclax + azacitidine for newly diagnosed AML patients unfit for intensive chemotherapy. Crucially no dose-limiting toxicities or cytokine release syndrome (CRS) have been observed to date across the trial. Why It Matters: High-Impact Efficacy: XXX% remission in Cohort X with XX% of patients achieving"  
[X Link](https://x.com/RedChip/status/1975534118478786577) [@RedChip](/creator/x/RedChip) 2025-10-07T12:10Z 5886 followers, XXX engagements


"🎥 Nova Minerals: CEO Chris Gerteisen on Gold & Antimony Strategy @NovaMinerals $NVA is advancing its XXX sq. mile Estelle Project in Alaska already defining nearly 10Moz of gold and uncovering high-grade antimony: a critical mineral now in U.S. defense focus. Why It Matters: With gold and antimony both at record highs $NVA is uniquely positioned at the intersection of precious metals growth and critical U.S. supply chain security. Watch CEO Chris Gerteisens full interview for insights on strategy milestones and the road to production: $NVA $MP $PPTA $TECK $KGC $USGO $NG $THM $WRN $HL $GPH"  
[X Link](https://x.com/RedChip/status/1979191925463732646) [@RedChip](/creator/x/RedChip) 2025-10-17T14:25Z 5893 followers, XXX engagements


"🌿 Good Salt Life $NDTP: Expanding EPA Registrations and Advancing Biosecurity Leadership Good Salt Life a subsidiary of NDT Pharmaceuticals $NDTP has submitted a new EPA me-too registration for its hypochlorous acid disinfectant targeting efficacy claims for Clostridioides difficile (C. diff) a leading cause of hospital-acquired infections. The company's growing eco-friendly product line including recently registered Dog Gone Odor and PurrGuard continues to reinforce NDT Pharmaceuticals mission to protect people pets and the planet. Read the Full Announcement: $NDTP $CL $NEPT $CHD $CLX $PG"  
[X Link](https://x.com/RedChip/status/1976274722284355590) [@RedChip](/creator/x/RedChip) 2025-10-09T13:13Z 5888 followers, XXX engagements


"🔔 NioCorp $NB: Exclusive Investor Webinar with CEO Mark Smith & COO Scott Honan Join @NioCorps leadership team for a live investor webinar on Monday October XX at 11:00 AM ET. Get direct insights on: Progress toward project financing for the Elk Creek Critical Minerals Project Recent $162.8M cash position and capital raise details U.S. DoW support and long-term offtake agreements Save your seat now: $NB $MP $ARA $ILU $PPTA $TECK $KGC $USGO $NG $THM $WRN $HL $GPH $NST $FVL $CTGO"  
[X Link](https://x.com/RedChip/status/1978453832494453114) [@RedChip](/creator/x/RedChip) 2025-10-15T13:32Z 5894 followers, XXX engagements


"📢 Join XX Degrees Pharmaceuticals $SXTP for a Live Investor Webinar Learn how $SXTP is advancing infectious disease treatments with its FDA-approved malaria drug ARAKODA and a growing pipeline targeting babesiosis and other emerging threats. Date: Wednesday October XX Time: 4:15 PM EST Reserve Your Spot Now: $SXTP $VRTX $LLY $NVO $PFE $VALN $REGN"  
[X Link](https://x.com/RedChip/status/1975896489852285341) [@RedChip](/creator/x/RedChip) 2025-10-08T12:10Z 5889 followers, XXX engagements


"🧬 XX Degrees Pharma $SXTP: Early Success in Tackling Relapsing Babesiosis with Tafenoquine XX Degrees Pharmaceuticals has reported no detection of Babesia infection in the first patient treated in its relapsing babesiosis study using tafenoquine an important milestone in its FDA pathway. Why This Matters to Investors: Breakthrough Therapy Designation request submitted to the FDA No current FDA-approved treatment for babesiosis a life-threatening tick-borne illness in immunosuppressed patients The full study is expected to conclude by October 2026 aiming to confirm tafenoquines high cure rate"  
[X Link](https://x.com/RedChip/status/1978441405195223084) [@RedChip](/creator/x/RedChip) 2025-10-15T12:42Z 5889 followers, XXX engagements


"😎 $NVA $MP $PPTA $TECK $KGC $USGO $NG $THM $WRN $HL $GPH $NST $FVL $CTGO $XAU $XAUUSD"  
[X Link](https://x.com/RedChip/status/1978443242891841616) [@RedChip](/creator/x/RedChip) 2025-10-15T12:50Z 5889 followers, XXX engagements


"📊 BTCS $BTCS: An Ethereum-First Public Blockchain Company In just XX seconds see how @NasdaqBTCS is scaling Ethereum infrastructure with: Proprietary Builder+ platform driving block building revenue Validator node operations generating staking rewards A DeFi/TradFi flywheel designed to enhance shareholder value Watch our quick overview and discover why $BTCS is positioned as one of the most sophisticated public Ethereum plays. Overview Here: $BTCS $COIN $RIOT $HIVE $MARA $NVDA $ETH $SQ"  
[X Link](https://x.com/RedChip/status/1975904010969256202) [@RedChip](/creator/x/RedChip) 2025-10-08T12:40Z 5889 followers, 70.5K engagements


"🎙 Must-Watch Interview: Fraser Atkinson CEO of @GreenPowerBus Talks EV Strategy & Growth $GP is driving the electrification of transportation with a purpose-built all-electric lineup of buses and trucks. With 900+ zero-emission vehicles built and $90M+ in revenue generated over the past three years the company is capitalizing on strong regulatory tailwinds and growing demand for clean transit solutions. Why Investors Should Tune In: Undervalued Opportunity: Trades at 1x TTM sales well below peers like Workhorse $WKHS. Profitability Edge: Only peer with positive gross profit. Strategic"  
[X Link](https://x.com/RedChip/status/1979181871570252083) [@RedChip](/creator/x/RedChip) 2025-10-17T13:45Z 5893 followers, 11.8K engagements


"📢 Foremost Clean Energy $FMST: Strategic Advantage in the Athabasca Basin In our latest interview CEO Jason Barnard highlights how @FMSTCleanEnergy's partnership with Denison Mines $DNN and proximity to world-class producers like Cameco set the stage for outsized upside: Why This Matters for Investors: 330000+ acres across XX properties in the Athabasca Basin one of the richest uranium districts in the world Fully funded $6.5M exploration program in 2025 with active drill campaigns at Murphy Lake and Hatchet Lake Direct access to Denisons ISR expertise and data advantage accelerating"  
[X Link](https://x.com/RedChip/status/1978815761356382342) [@RedChip](/creator/x/RedChip) 2025-10-16T13:30Z 5893 followers, 20.6K engagements


"🎙 Investor Spotlight: Geoff Dow CEO of XX Degrees Pharmaceuticals $SXTP Shares Strategic Vision $SXTP is taking aim at infectious diseases with precision. In our latest interview President & CEO Geoff Dow discusses how $SXTP is advancing its antifungal and antiviral pipeline while scaling commercialization of ARAKODA: an FDA-approved malaria prophylactic with XXX% YoY sales growth in Q3 2024. Why Investors Should Tune In: Strong Market Traction: ARAKODA is revenue-generating and FDA-approved with growth accelerating. Strategic Expansion: Upcoming pivotal study in babesiosis a tick-borne"  
[X Link](https://x.com/RedChip/status/1978474732505739457) [@RedChip](/creator/x/RedChip) 2025-10-15T14:55Z 5893 followers, 26.3K engagements


"🎥 Nova Minerals $NVA: Watch This 30-Second Snapshot of a Hidden Asset in Alaska's Gold & Antimony Boom @NovaMinerals is advancing one of North America's most promising undeveloped gold and antimony projects at its XXX km Estelle Project in Alaskas prolific Tintina Gold Belt: home to 220Moz of gold deposits. Why Investors Should Watch: Tier X Scale: Two multi-million oz gold resources already defined. Critical Minerals Upside: High-grade antimony with active U.S. DoW collaboration. With gold and antimony at record highs $NVA offers strategic leverage in two vital commodities. Watch the"  
[X Link](https://x.com/RedChip/status/1977742397057425539) [@RedChip](/creator/x/RedChip) 2025-10-13T14:25Z 5888 followers, XXX engagements


"🧬 Aptevo Therapeutics $APVO Showcasing Scientific and Clinical Updates at Leading Conferences in Q4 Upcoming Conference Schedule: ROTH Healthcare Opportunities Conference (Oct X NYC): Panel discussion on Novel AML Therapies featuring data from the RAINIER trial of lead candidate mipletamig demonstrating strong safety and early efficacy in frontline AML. BIO-Europe 2025 (Nov XX Vienna): Business Development Team engaging in global partnering to expand Aptevos collaborations. SITC 2025 (Nov XX Maryland): Poster presentation on a trispecific antibody targeting Nectin-4/CD3/CD40 to address the"  
[X Link](https://x.com/RedChip/status/1975908847647592537) [@RedChip](/creator/x/RedChip) 2025-10-08T12:59Z 5888 followers, XXX engagements


"Join BioVie's CEO for our investor webinar: live now $BIVI $PACB $VYGR $PFE $MRK"  
[X Link](https://x.com/RedChip/status/1976020535583662372) [@RedChip](/creator/x/RedChip) 2025-10-08T20:23Z 5888 followers, XXX engagements


"🎥 XX Degrees Pharmaceuticals: Watch the 30-Second Investor Overview XX Degrees Pharmaceuticals $SXTP is advancing next-gen therapies for infectious diseases with a strong focus on late-stage clinical assets. Why Investors Should Watch: Revenue Momentum: ARAKODA malaria prevention sales surged XXX% YoY in Q3 2024. Clinical Expansion: Tafenoquine entering a pivotal trial for babesiosis a growing tick-borne threat with 47000 U.S. cases annually. Capital-Efficient Model: Leverages existing data to accelerate development and reduce risk across its pipeline. See the Big Picture in Just XX Seconds:"  
[X Link](https://x.com/RedChip/status/1977749963162477026) [@RedChip](/creator/x/RedChip) 2025-10-13T14:55Z 5893 followers, 45.7K engagements


"🎥 XX Degrees Pharmaceuticals: Watch the 30-Second Investor Overview XX Degrees Pharmaceuticals $SXTP is advancing next-gen therapies for infectious diseases with a strong focus on late-stage clinical assets. Why Investors Should Watch: Revenue Momentum: ARAKODA malaria prevention sales surged XXX% YoY in Q3 2024. Clinical Expansion: Tafenoquine entering a pivotal trial for babesiosis a growing tick-borne threat with 47000 U.S. cases annually. Capital-Efficient Model: Leverages existing data to accelerate development and reduce risk across its pipeline. See the Big Picture in Just XX Seconds:"  
[X Link](https://x.com/RedChip/status/1965066378219573267) [@RedChip](/creator/x/RedChip) 2025-09-08T14:55Z 5889 followers, XXX engagements


"Join @JackpotDigital $JPOTF's CEO for our investor webinar followed by a Q&A session: live now $JPOTF $MGM $LVS $CZR $DKNG $WYNN $BYD $VICI $IGT $PENN"  
[X Link](https://x.com/RedChip/status/1978922146840641653) [@RedChip](/creator/x/RedChip) 2025-10-16T20:33Z 5891 followers, XXX engagements


"🚀 BioVie Inc. Targeting Major Breakthroughs in Neurology & Liver Disease $BIVI is advancing innovative therapies in high-need markets including Alzheimers Parkinsons Long COVID and liver cirrhosis. With multiple clinical-stage assets and a fully funded Parkinsons Phase 2b trial launching in late 2024 the company is gearing up for a catalyst-rich year ahead. Why This Matters for Investors: Multiple Shots on Goal: Active programs in Alzheimers (Phase 3) Parkinsons (Phase 2b) Long COVID (Phase 2) and liver disease (Phase 3-ready). Regulatory Momentum: FDA Fast Track status for BIV201 in liver"  
[X Link](https://x.com/RedChip/status/1976265161439686864) [@RedChip](/creator/x/RedChip) 2025-10-09T12:35Z 5888 followers, 67.9K engagements